Doximity, Inc.
DOCS Healthcare Health Information Services
Doximity, Inc.’s revenue for fiscal 2026 (year ended March 2026) was $644.9 million, up 13.1% from fiscal 2025.
- Revenue
- +3.57%
- EPS
- −42.4%
- Free cash flow
- +1.87%
Quarter to September 2026, against a year earlier
Follow DOCS
Alert me
Doximity, Inc. (DOCS) Current ratio
Doximity, Inc.'s current ratio at the end of the quarter to 30 September 2026 was 6.4×, up 0.3× from fiscal 2026 (6.1×). Over the past ten years it has ranged from 2.1× (fiscal 2021) to 8.1× (fiscal 2022); the current reading is higher than 43% of that period. That is above the Health Information Services industry median of 2.1× and above the Healthcare sector median of 3.1×.
Current ratio, annual
Embed this chart
Annual newest first
| Period | Current ratio | Change |
|---|---|---|
| FY2026 | 6.1× | (12.54%) |
| FY2025 | 7.0× | 12.37% |
| FY2024 | 6.2× | (11.33%) |
| FY2023 | 7.0× | (13.94%) |
| FY2022 | 8.1× | 295.92% |
| FY2021 | 2.1× | (7.03%) |
| FY2020 | 2.2× | — |
Quarterly newest first
| Period | Current ratio | Change |
|---|---|---|
| Sep 2026 | 6.4× | 4.85% |
| Jun 2026 | 6.1× | (0.24%) |
| Mar 2026 | 6.1× | (8.09%) |
| Dec 2025 | 6.6× | (14.86%) |
| 21 more quarters | Free account |
Against its own ten years
Current ratio against peers
| Company | Current ratio |
|---|---|
| DOCS Doximity, Inc. | 6.4× |
| HTFL Heartflow, Inc. compare | 5.1× |
| HQY HealthEquity, Inc. compare | 3.0× |
| SDGR Schrodinger, Inc. compare | 2.7× |
| TEM Tempus AI, Inc. compare | 2.6× |
| WAY Waystar Holding Corp. compare | 2.1× |
| PRVA Privia Health Group, Inc. compare | 1.6× |
| BTSG BrightSpring Health Services, Inc. compare | 1.6× |
| HNGE Hinge Health Inc. compare | 1.3× |
| Health Information Services industry median | 2.1× |
| Healthcare sector median | 3.1× |
| Market median | 1.6× |
What Current ratio is
Current Ratio shows whether a company’s short-term assets are enough to cover the bills and debts it must pay within the next year.
Current Assets (Total) ÷ Current Liabilities (Total)
More on DOCS
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement